Sinopharm Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SHTD.Y?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	159,009	0.0051%
General Public	442,805,380	14.2%
Institutions	898,846,351	28.8%
Private Companies	1,778,845,451	57%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 81.99% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
57%	China National Pharmaceutical Group Corporation	1,778,845,451	US$5.0b	0%	no data
4.82%	FMR LLC	150,404,494	US$425.0m	-6.91%	0.02%
3.68%	Lazard Asset Management LLC	114,698,209	US$324.1m	5.04%	0.28%
3.51%	CITIC Securities Company Limited, Asset Management Arm	109,432,400	US$309.3m	0%	2.39%
2.16%	JP Morgan Asset Management	67,391,572	US$190.4m	-18.9%	0.02%
1.71%	BlackRock, Inc.	53,519,016	US$151.2m	-29.4%	no data
1.68%	The Vanguard Group, Inc.	52,561,305	US$148.5m	0.33%	no data
1.18%	Dimensional Fund Advisors LP	36,712,758	US$103.7m	0.22%	0.02%
0.87%	State Street Global Advisors, Inc.	27,131,813	US$76.7m	2.2%	no data
0.7%	Wasatch Advisors LP	21,725,600	US$61.4m	63%	0.2%
0.69%	Bosera Asset Management Co., Ltd.	21,446,800	US$60.6m	0%	0.26%
0.53%	Norges Bank Investment Management	16,398,891	US$46.3m	0%	no data
0.45%	Nordea Investment Management, AB	14,196,365	US$40.1m	-0.75%	0.03%
0.45%	Swedbank Robur Fonder AB	13,986,463	US$39.5m	0%	0.03%
0.41%	Value Partners Hong Kong Limited	12,833,600	US$36.3m	0%	1.4%
0.37%	Geode Capital Management, LLC	11,512,387	US$32.5m	1.66%	no data
0.3%	Charles Schwab Investment Management, Inc.	9,331,689	US$26.4m	0.82%	no data
0.25%	China Asset Management Co. Ltd.	7,803,716	US$22.1m	-0.05%	0.02%
0.24%	UBS Asset Management AG	7,437,729	US$21.0m	22%	no data
0.23%	Andra AP-fonden	7,054,800	US$19.9m	0%	0.11%
0.18%	Bin Yuan Capital Limited	5,560,753	US$15.7m	0%	2.87%
0.18%	JPMorgan Chase & Co, Brokerage and Securities Investments	5,488,148	US$15.5m	-27.5%	0.01%
0.15%	Hang Seng Investment Management Limited	4,664,810	US$13.2m	0%	0.13%
0.14%	Pacific Investment Management Company LLC	4,344,800	US$12.3m	5.19%	0.04%
0.14%	Guotai Asset Management Company Limited	4,264,388	US$12.1m	0%	0.05%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 21:19
End of Day Share Price	2024/12/24 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sinopharm Group Co. Ltd. is covered by 43 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jason Mann	Barclays
Derrick Sun	BNP Paribas Securities (Asia)
Bo Li	BofA Global Research